Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3873450012 | Elexacaftor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3873451011 | Elexacaftor (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Elexacaftor | Is a | Pyridine | true | Inferred relationship | Some | ||
Elexacaftor | Has disposition (attribute) | Cystic fibrosis transmembrane conductance regulator potentiator (disposition) | true | Inferred relationship | Some | ||
Elexacaftor | Is a | Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Elexacaftor- and ivacaftor- and tezacaftor-containing product | Has active ingredient | True | Elexacaftor | Inferred relationship | Some | 3 |
Product containing elexacaftor and ivacaftor and tezacaftor in oral dose form (medicinal product form) | Has active ingredient | True | Elexacaftor | Inferred relationship | Some | 3 |
Elexacaftor and ivacaftor and tezacaftor only product | Has active ingredient | True | Elexacaftor | Inferred relationship | Some | 3 |
Product containing only elexacaftor and ivacaftor and tezacaftor in oral dose form (medicinal product form) | Has active ingredient | True | Elexacaftor | Inferred relationship | Some | 3 |
Reference Sets